Vertex (VRTX) PT Raised to $235 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Vertex (VRTX) PT Raised to $247 at Piper Jaffray
October 31, 2019 4:26 AM EDTPiper Jaffray analyst Edward Tenthoff raised the price target on Vertex (NASDAQ: VRTX) to $247.00 (from $230.00) while maintaining a Overweight rating.... More
Vertex Pharma (VRTX) Tops Q3 EPS by 8c; Offers FY19 Revenue Outlook
October 30, 2019 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.23, $0.08 better than the analyst estimate of $1.15. Revenue for the quarter came in at $950 million versus the consensus estimate of $950.9 million.
"2019 has been a year of significant progress for Vertex across all parts of our... More
